Home » Newsletters » BioWorld

BioWorld

Jan. 9, 2001

View Archived Issues

DNA Sciences Seeks $125M In IPO For Genetics Discovery

Other News To Note

Cubist Getting Up To $44M From Gilead Through Daptomycin Deal

NeoGenesis Raises $23M In 4th Round To Fund Programs

Syrrx Raises $54M Privately For Protein Structure Determination

FDA Denies Approval Of Aronex's Atragen; Stock Falls 73 Percent

Ligand Completes $24M Private Financing For Various Programs

Three Friendly Rivals Unanimous: Seek Major AD Risk-Factor Gene On Chromosome 10 Hotspot Site

OSI's Double Deal For Cancer Drug: Genentech, Roche Pay Up To $187M

Genentech CEO: Keep It Simple - And Give Up On Trial Failures

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...